Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Boston Scientific Buys EndoChoice, Mulls De-FUSEing Potential Weakness

Boston Scientific is making a significant investment in its endoscopy portfolio as it strikes a $210m deal to buy colonoscopy specialist EndoChoice. The Natick, Massachusetts, group added that it will be “evaluating strategic options” for EndoChoice’s Fuse colonoscope.

Gastroenterology M and A Deals

Coordinating Antibiotics, Test Development Could Shorten Approval Times, US FDA Says

In a new draft guidance, the agency recommends antimicrobial drug developers and sponsors of antimicrobial susceptibility tests coordinate their regulatory submissions to get their products on the market together faster.

Policy and Regulation Diagnostics Medical Device

China VC Watch: Genome, Diagnostics Ventures Attract New Funding

Genetron Health is the latest emerging Chinese biotech to attract new capital in the push toward precision medicine in China, while the Lilly Asia Fund is among the investors in cancer diagnosis venture Singlera’s Series A.

China StartUps and SMEs In Vitro Diagnostics

Device Week – September 26, 2016

On this week's podcast, we discuss wound-care firm Advanced Medical Solutions, the latest developments for the US National Evaluation System for health Technology, and the debate over laboratory-development test regulations.

Medical Device United States United Kingdom

Recent Tweets from Medtech Insight

Policy & Regulation

Set Alert for Policy & Regulation

EU Regulation Recap: Chapter V Demonstrates Conformity Assessment Routes For Each Risk Class

What procedures will manufacturers need to follow to comply with the future medical device and IVD regulations, and when will a notified body need to be involved? A look at these issues as addressed in the fifth chapter of the pending regulatory documents.

Europe Policy and Regulation Medical Devices

US FDA Agrees To CLIA Waiver Process Reforms, But More Is Needed, Coalition Says

Despite FDA's efforts to centralize CLIA waiver reviews and bring more consistency to the process, one reform group tied to the diagnostics industry says the agency is not addressing the real problem: the fundamental standard for a waiver determination that FDA established in a 2008 guidance.

In Vitro Diagnostics Policy and Regulation Legislation

Latest From Policy and Regulation

Eurasian Medtech System Expects More Progress This Fall

More building blocks of the Eurasian Economic Union’s common medical technology regulatory system are falling into place – but are developments taking place fast enough for an early 2017 launch?

Russian Federation Kazakhstan

More EU Clinical Data Requirements Coming With New Regulations

In the EU, a two-step strengthening of requirements for clinical data means manufacturers and notified bodies need to act now, well ahead of the new Medical Device Regulations taking effect. Sarah Sorrel, president of device clinical research organization Medpass International, explains how and why in this guest column.

Medical Device Europe

US House Members Urge Hearings On Device Safety

A bipartisan coalition of seven members of the US House asked Energy and Commerce Committee leaders to hold hearings on medical device safety, trying to bring more attention to provisions that might strengthen safety oversight amid all the talk of accelerating medical innovation.

Legislation Policy and Regulation

Podcast: Regs May Be Warranted To Protect Shared Medtech Data

The CEO of the National Organization for Rare Disorders spoke with Medtech Insight at the Medical Device Innovation Consortium 2016 Public Forum. Peter Saltonstall said regulatory steps may be needed to support efforts to get companies to share clinical data to support precision medicine and a National Evaluation System for health Technology.

Policy and Regulation Innovation

Deadline Reprieve Mooted For Russian Registration Replacements

Medtech companies are being warned that if they do not renew their registration certificates in Russia by the start of 2017, their certificates will become invalid.

Russian Federation Regulation

FDA Panel Supports Class II For Wound Dressings, But More Controls When Antibiotics Are Added

Most experts on US FDA’s General & Plastic Surgery Devices Advisory Committee recommended Sept. 21 that drug-containing wound dressings should be placed in the class II risk category, but some pushed for more oversight of products containing antibiotics, with some panelists recommending class III placement in those instances.

Policy and Regulation Regulation


Set Alert for Commercial

Five Charged In $20m Embezzlement At Hearing Aid Company

Three former executives at hearing aid company Starkey Laboratories, along with two outside conspirators, are facing federal fraud, conspiracy and money-laundering charges. The defendants reportedly stole more than $20m via a complicated web of sham companies between 2006 and 2015.

United States Commercial Medical Device

Latest From Commercial

Reapplix Seals In More Funding For Diabetic Foot Ulcer Patch

Reapplix, an emerging autologous cell-based wound therapy specialist, has secured additional funding that will take the company through the next year before it gets “market-ready” to launch its diabetic foot ulcer treatment in the US and EU.

Diabetic Care Wound Management

GE Will Back Start-Ups Shooting For Improved Global Health

GE Healthcare has launched a health-care accelerator program to support global-health start-ups aiming to improve health-care quality and accessibility in developing economies.

StartUps and SMEs Financing

AMS Seeks To Stitch In More M&A Deals

Advanced Medical Solutions is on the hunt for acquisition opportunities to grow its wound-care business following a 20% increase in revenue during the first half of 2016.

Wound Management Financial Reports

Plaintiff Gets New Trial In Boston Sci Mesh Case

A Massachusetts state appeals court sent a verdict favoring the company back to the county court for reconsideration. The higher court found the judge in the original case acted improperly by keeping information relevant to mesh safety concerns from the jury.

Legal Commercial

Edwards, Boston Sci Make TAVR Progress In Europe

Edwards Lifesciences' Sapien 3 transcatheter aortic heart valve is now labeled in Europe for use in patients who face an intermediate risk from open-heart surgery, matching a recent US development. Meanwhile, Boston Scientific's next-generation Lotus Edge TAVR device gained a CE mark.

Medical Device Cardiology

Device Week – September 19, 2016

On this week's podcast, Tina Tan and David Filmore discuss the ophthalmology market; in particular, Tina's recent interview with James Mazzo, and the planned sale of Abbott Medical Optics to Johnson & Johnson for more than $4bn.

Medical Device Ophthalmic

Clinical R&D

Set Alert for Clinical R&D

Robert Byrne: Absorb, Synergy, And The Future Of Coronary Stents

One of the most controversial, and potentially impactful, questions in medical device development today is how to better prevent late events, especially late stent-thrombosis, in coronary stent patients. The two leading answers to this question are a completely bioresorbable drug-eluting stent and a metal drug-eluting stent with a bioresorbable polymer, but there may be even more ideas on the horizon. One of the leading experts in the field and a cardiologist with experience with most of these new technologies, Robert Byrne of Deutsches Herzzentrum in Munich, recently talked to Medtech Insight about the questions that still need to be answered in this field and how it can move forward.

Cardiovascular Innovation Clinical Trials

Latest From Research and Development

Medtronic Neurosurgery Software Gains US FDA Clearance

The application helps surgeons effectively place deep brain stimulation leads during cranial surgery.

Research and Development Medical Device

Glaukos' Micro-Bypass Stents Work As First-Line Glaucoma Therapy

Results of a 101-patient randomized clinical trial show that implantation of two iStent Trabecular Micro-Bypass stents is a viable initial treatment option, comparable to topical ocular hypotensive medications, in patients with newly diagnosed primary open-angle glaucoma.

Clinical Trials Research and Development

Medtronic Artificial Pancreas Trial Results Published

Medtronic’s Hybrid closed-loop system is safe and improves some key patient outcomes, according to results published in the Journal of the American Medical Association. The system is currently before FDA for review.

Research and Development Medical Device

FDA Issues How-To On Computational Modeling Reports

The document, which finalizes a 2014 draft guidance, details 15 key areas device-makers should include in device-submission reports on computer modeling and simulation.

United States Research and Development

Expert Webinar Explores Pressing Questions About Biosorbable Stent Technology

Boston Scientific and inVentive Health recently sponsored a webinar with four internationally well-known experts on coronary stent technology to discuss the pros and cons of new bioabsorbable polymer stent technologies – both the fully resorbable stents and metal drug-eluting stents with a bioresorbable polymer. Here's a summary of the discussion. Medtech Insight is also providing a complete transcript of the event.

Cardiovascular Innovation

Robotic Arm Inventor Says 18 Months ‘Too Long’ To Approve Novel Device

US FDA needs to speed up its approval procedures for review of revolutionary devices like the LUKE prosthetic arm, says its inventor Dean Kamen. The arm was launched by Mobius Bionics on July 8. Kamen took a few moments after testifying at a House robotics hearing to explain its capabilities to Medtech Insight and share his thoughts about the FDA device review process and the spirit behind the 21st Century Cures bill.

Regulation Innovation